H.R. 5950
Referred to CommitteeImproving Patient Access to Care and Treatment Act
Latest Action
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
11/1/2022 • House
Summary
Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
Introduced in House • 11/12/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (7)
Party Breakdown
Sponsor
Cosponsors (6)
Bill Journey
Originated in the House
Introduced
November 12, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (2)
H.R. 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
S. 3257
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.